Hypokalemia

Last updated

Hypokalemia
Other namesHypokalaemia, hypopotassaemia, hypopotassemia
LowKECG.JPG
An ECG in a person with a potassium level of 1.1 meq/L showing the classical changes of ST segment depression, inverted T waves, large U waves, and a slightly prolonged PR interval.
Specialty Critical care medicine
Symptoms Feeling tired, leg cramps, weakness, constipation, abnormal heart rhythm [1]
Complications Cardiac arrest [1]
Causes Diarrhea, medications like furosemide and steroids, dialysis, diabetes insipidus, hyperaldosteronism, hypomagnesemia, not enough intake in the diet [1]
Diagnostic method Blood potassium < 3.5 mmol/L [1] [2]
TreatmentDietary changes, potassium supplements, based on the underlying cause [3]
Frequency20% of people admitted to hospital [4]

Hypokalemia is a low level of potassium (K+) in the blood serum. [1] Mild low potassium does not typically cause symptoms. [3] Symptoms may include feeling tired, leg cramps, weakness, and constipation. [1] Low potassium also increases the risk of an abnormal heart rhythm, which is often too slow and can cause cardiac arrest. [1] [3]

Contents

Causes of hypokalemia include vomiting, diarrhea, medications like furosemide and steroids, dialysis, diabetes insipidus, hyperaldosteronism, hypomagnesemia, and not enough intake in the diet. [1] Normal potassium levels in humans are between 3.5 and 5.0 mmol/L (3.5 and 5.0 mEq/L) with levels below 3.5 mmol/L defined as hypokalemia. [1] [2] It is classified as severe when levels are less than 2.5 mmol/L. [1] Low levels may also be suspected based on an electrocardiogram (ECG). [1] The opposite state is called hyperkalemia that means high level of potassium in the blood serum. [1]

The speed at which potassium should be replaced depends on whether or not there are symptoms or abnormalities on an electrocardiogram. [1] Potassium levels that are only slightly below the normal range can be managed with changes in the diet. [3] Lower levels of potassium require replacement with supplements either taken by mouth or given intravenously. [3] If given intravenously, potassium is generally replaced at rates of less than 20 mmol/hour. [1] Solutions containing high concentrations of potassium (>40 mmol/L) should generally be given using a central venous catheter. [3] Magnesium replacement may also be required. [1]

Hypokalemia is one of the most common water–electrolyte imbalances. [4] It affects about 20% of people admitted to hospital. [4] The word hypokalemia comes from hypo- 'under' + kalium 'potassium' + -emia 'blood condition'. [5]

Signs and symptoms

Mild hypokalemia is often without symptoms, although it may cause elevation of blood pressure, [6] and can provoke the development of an abnormal heart rhythm. Severe hypokalemia, with serum potassium concentrations of 2.5–3 meq/L (Nl: 3.5–5.0 meq/L), may cause muscle weakness, myalgia, tremor, and muscle cramps (owing to disturbed function of skeletal muscle), and constipation (from disturbed function of smooth muscle). With more severe hypokalemia, flaccid paralysis and hyporeflexia may result. Reports exist of rhabdomyolysis occurring with profound hypokalemia with serum potassium levels less than 2 meq/L. [7] Respiratory depression from severe impairment of skeletal muscle function is found in some people. [8] Psychological symptoms associated with severe hypokalemia can include delirium, hallucinations, depression, or psychosis. [9] [10]

Causes

Hypokalemia can result from one or more of these medical conditions:

Inadequate potassium intake

Not eating a diet with enough potassium-containing foods or fasting can cause the gradual onset of hypokalemia. This is a rare cause and may occur in those with anorexia nervosa or those on a ketogenic diet.[ citation needed ]

Gastrointestinal or skin loss

A more common cause is excessive loss of potassium, often associated with heavy fluid losses that flush potassium out of the body. Typically, this is a consequence of diarrhea, excessive perspiration, losses associated with crush injury, or surgical procedures. Vomiting can also cause hypokalemia, although not much potassium is lost from the vomitus. Rather, heavy urinary losses of K+ in the setting of post-emetic bicarbonaturia force urinary potassium excretion. (See discussion of alkalosis below.) Other gastrointestinal causes include pancreatic fistulae and the presence of adenoma.[ citation needed ]

Urinary loss

Distribution away from extracellular fluid

Other

Pseudohypokalemia

Pathophysiology

About 98% of the body's potassium is found inside cells, with the remainder in the extracellular fluid including the blood. This concentration gradient is maintained principally by the Na+/K+ pump.[ citation needed ]

Potassium is essential for many body functions, including muscle and nerve activity. The electrochemical gradient of potassium between the intracellular and extracellular space is essential for nerve function; in particular, potassium is needed to repolarize the cell membrane to a resting state after an action potential has passed. Lower potassium levels in the extracellular space cause hyperpolarization of the resting membrane potential. This hyperpolarization is caused by the effect of the altered potassium gradient on resting membrane potential as defined by the Goldman equation. As a result, a greater-than-normal stimulus is required for depolarization of the membrane to initiate an action potential.[ citation needed ]

In the heart, hypokalemia causes arrhythmias because of less-than-complete recovery from sodium-channel inactivation, making the triggering of an action potential less likely. In addition, the reduced extracellular potassium (paradoxically) inhibits the activity of the IKr potassium current and delays ventricular repolarization. This delayed repolarization may promote reentrant arrhythmias. [25]

Diagnosis

Blood

Normal potassium levels are between 3.5 and 5.0 mmol/L with levels below 3.5 mmol/L (less than 3.5 mEq/L) defined as hypokalemia. [1] [26]

Electrocardiogram

Hypokalemia leads to characteristic ECG changes (PR prolongation, ST-segment and T-wave depression, U-wave formation). [4]

The earliest ECG findings, associated with hypokalemia, are decreased T wave height. Then, ST depressions and T inversions appear as serum potassium levels reduce further. Due to prolonged repolarization of ventricular Purkinje fibers, prominent U waves occur (usually seen at V2 and V3 leads), frequently superimposed upon T waves, therefore producing the appearance of prolonged QT intervals, when serum potassium levels fall below 3 mEq/L. [27]

Amount

The amount of potassium deficit can be calculated using the following formula:
Kdeficit (in mmol) = (Knormal lower limit − Kmeasured) × body weight (kg) × 0.4
Meanwhile, the daily body requirement of potassium is calculated by multiplying 1 mmol to body weight in kilograms. Adding potassium deficit and daily potassium requirement would give the total amount of potassium need to be corrected in mmol. Dividing mmol by 13.4 will give the potassium in grams. [28]

Treatment

Treatment includes addressing the cause, such as improving the diet, treating diarrhea, or stopping an offending medication. People without a significant source of potassium loss and who show no symptoms of hypokalemia may not require treatment. Acutely, repletion with 10 mEq of potassium is typically expected to raise serum potassium by 0.1 mEq/L immediately after administration. However, for those with chronic hypokalemia, repletion takes time due to tissue redistribution. For example, correction by 1 mEq/L can take more than 1000 mEq of potassium over many days. [6]

Oral potassium supplementation

Mild hypokalemia (>3.0 mEq/L) may be treated by eating potassium-containing foods or by taking potassium chloride supplements in a tablet or syrup form (by mouth supplements). Foods rich in potassium include dried fruits (particularly apricots, prunes and figs), nuts, bran cereals and wheat germ, lima beans, molasses, leafy green vegetables, broccoli, winter squash, beets, carrots, cauliflower, potatoes, avocados, tomatoes, coconut water, citrus fruits (particularly oranges), cantaloupe, kiwis, mangoes, bananas, and red meats. [29] [30]

Eating potassium-rich foods may not be sufficient for correcting low potassium; potassium supplements may be recommended. Potassium contained in foods is almost entirely coupled with phosphate and is thus ineffective in correcting hypokalemia associated with hypochloremia that may occur due to vomiting, diuretic therapy, or nasogastric drainage. Additionally, replacing potassium solely through diet may be costly and result in weight gain due to potentially large amounts of food needed. An effort should also be made to limit dietary sodium intake due to an inverse relationship with serum potassium. Increasing magnesium intake may also be beneficial for similar physiological reasons. [30]

Potassium chloride supplements by mouth have the advantage of containing precise quantities of potassium, but the disadvantages of a taste which may be unpleasant, and the potential for side-effects including nausea and abdominal discomfort. Potassium bicarbonate is preferred when correcting hypokalemia associated with metabolic acidosis. [30]

Intravenous potassium replacement

Severe hypokalemia (<3.0 mEq/L) may require intravenous supplementation. Typically, a saline solution is used, with 20–40 meq/L KCl per liter over 3–4 hours. [31] Giving IV potassium at faster rates (20–25 meq/hr) may inadvertently expose the heart to a sudden increase in potassium, potentially causing dangerous abnormal heart rhythms such as heart block or asystole. [25] Faster infusion rates are therefore generally only performed in locations in which the heart rhythm can be continuously monitored such as a critical care unit. [31] When replacing potassium intravenously, particularly when higher concentrations of potassium are used, infusion by a central line is encouraged to avoid the occurrence of a burning sensation at the site of infusion, or the rare occurrence of damage to the vein. [32] When peripheral infusions are necessary, the burning can be reduced by diluting the potassium in larger amounts of fluid, or adding a small dose of lidocaine to the intravenous fluid, [31] although adding lidocaine may increase the likelihood of medical errors. [33] Even in severe hypokalemia, oral supplementation is preferred given its safety profile. Sustained-release formulations should be avoided in acute settings.[ citation needed ]

Potassium-sparing diuretics

Hypokalemia which is recurrent or resistant to treatment may be amenable to a potassium-sparing diuretic, such as amiloride, triamterene, spironolactone, or eplerenone. Concomitant hypomagnesemia will inhibit potassium replacement, as magnesium is a cofactor for potassium uptake. [30]

The plot of the science fiction novel Destiny's Road by Larry Niven centers around the setting's scarcity of available potassium, and the resulting deficiency and its effects on the world's colonists and their society. [34] [35] [36] [37]

See also

Related Research Articles

Hyponatremia or hyponatraemia is a low concentration of sodium in the blood. It is generally defined as a sodium concentration of less than 135 mmol/L (135 mEq/L), with severe hyponatremia being below 120 mEq/L. Symptoms can be absent, mild or severe. Mild symptoms include a decreased ability to think, headaches, nausea, and poor balance. Severe symptoms include confusion, seizures, and coma; death can ensue.

<span class="mw-page-title-main">Ascites</span> Abnormal build-up of fluid in the abdomen

Ascites is the abnormal build-up of fluid in the abdomen. Technically, it is more than 25 ml of fluid in the peritoneal cavity, although volumes greater than one liter may occur. Symptoms may include increased abdominal size, increased weight, abdominal discomfort, and shortness of breath. Complications can include spontaneous bacterial peritonitis.

<span class="mw-page-title-main">Primary aldosteronism</span> Excess production of aldosterone in the adrenal gland

Primary aldosteronism (PA), also known as primary hyperaldosteronism, refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels and high blood pressure. This abnormality is a paraneoplastic syndrome. About 35% of the cases are caused by a single aldosterone-secreting adenoma, a condition known as Conn's syndrome.

<span class="mw-page-title-main">Furosemide</span> Loop diuretic medication

Furosemide, sold under the brand name Lasix among others, is a loop diuretic medication used to treat edema due to heart failure, liver scarring, or kidney disease. Furosemide may also be used for the treatment of high blood pressure. It can be taken intravenously or orally. When given intravenously, furosemide typically takes effect within five minutes; when taken orally, it typically metabolizes within an hour.

<span class="mw-page-title-main">Hypocalcemia</span> Low calcium levels in ones blood serum

Hypocalcemia is a medical condition characterized by low calcium levels in the blood serum. The normal range of blood calcium is typically between 2.1–2.6 mmol/L, while levels less than 2.1 mmol/L are defined as hypocalcemic. Mildly low levels that develop slowly often have no symptoms. Otherwise symptoms may include numbness, muscle spasms, seizures, confusion, or in extreme cases cardiac arrest.

Tumor lysis syndrome (TLS) is a group of metabolic abnormalities that can occur as a complication from the treatment of cancer, where large amounts of tumor cells are killed off (lysed) from the treatment, releasing their contents into the bloodstream. This occurs most commonly after the treatment of lymphomas and leukemias and in particular when treating non-Hodgkin lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia. This is a potentially fatal complication and patients at increased risk for TLS should be closely monitored while receiving chemotherapy and should receive preventive measures and treatments as necessary. TLS can also occur on its own although this is less common.

<span class="mw-page-title-main">Hyperkalemia</span> Excess potassium in the blood

Hyperkalemia is an elevated level of potassium (K+) in the blood. Normal potassium levels are between 3.5 and 5.0 mmol/L (3.5 and 5.0 mEq/L) with levels above 5.5 mmol/L defined as hyperkalemia. Typically hyperkalemia does not cause symptoms. Occasionally when severe it can cause palpitations, muscle pain, muscle weakness, or numbness. Hyperkalemia can cause an abnormal heart rhythm which can result in cardiac arrest and death.

<span class="mw-page-title-main">Electrolyte imbalance</span> Abnormality in the concentration of electrolytes in the body

Electrolyte imbalance, or water-electrolyte imbalance, is an abnormality in the concentration of electrolytes in the body. Electrolytes play a vital role in maintaining homeostasis in the body. They help to regulate heart and neurological function, fluid balance, oxygen delivery, acid–base balance and much more. Electrolyte imbalances can develop by consuming too little or too much electrolyte as well as excreting too little or too much electrolyte. Examples of electrolytes include calcium, chloride, magnesium, phosphate, potassium, and sodium.

<span class="mw-page-title-main">Loop diuretic</span> Diuretics that act along the loop of Henle in the kidneys

Loop diuretics are pharmacological agents that primarily inhibit the Na-K-Cl cotransporter located on the luminal membrane of cells along the thick ascending limb of the loop of Henle. They are often used for the treatment of hypertension and edema secondary to congestive heart failure, liver cirrhosis, or chronic kidney disease. While thiazide diuretics are more effective in patients with normal kidney function, loop diuretics are more effective in patients with impaired kidney function.

Hypernatremia, also spelled hypernatraemia, is a high concentration of sodium in the blood. Early symptoms may include a strong feeling of thirst, weakness, nausea, and loss of appetite. Severe symptoms include confusion, muscle twitching, and bleeding in or around the brain. Normal serum sodium levels are 135–145 mmol/L. Hypernatremia is generally defined as a serum sodium level of more than 145 mmol/L. Severe symptoms typically only occur when levels are above 160 mmol/L.

The syndrome of inappropriate antidiuretic hormone secretion (SIADH), also known as the syndrome of inappropriate antidiuresis (SIAD), is characterized by a physiologically inappropriate release of antidiuretic hormone (ADH) either from the posterior pituitary gland, or an abnormal non-pituitary source. Unsuppressed ADH causes a physiologically inappropriate increase in solute-free water being reabsorbed by the tubules of the kidney to the venous circulation leading to hypotonic hyponatremia.

Hypermagnesemia is an electrolyte disorder in which there is a high level of magnesium in the blood. Symptoms include weakness, confusion, decreased breathing rate, and decreased reflexes. Hypermagnesemia can greatly increase the chances of adverse cardiovascular events. Complications may include low blood pressure and cardiac arrest.

<span class="mw-page-title-main">Hypophosphatemia</span> Lack of phosphate in the blood

Hypophosphatemia is an electrolyte disorder in which there is a low level of phosphate in the blood. Symptoms may include weakness, trouble breathing, and loss of appetite. Complications may include seizures, coma, rhabdomyolysis, or softening of the bones.

<span class="mw-page-title-main">Gitelman syndrome</span> Genetic kidney disorder

Gitelman syndrome (GS) is an autosomal recessive kidney tubule disorder characterized by low blood levels of potassium and magnesium, decreased excretion of calcium in the urine, and elevated blood pH. It is the most frequent hereditary salt-losing tubulopathy. Gitelman syndrome is caused by disease-causing variants on both alleles of the SLC12A3 gene. The SLC12A3 gene encodes the thiazide-sensitive sodium-chloride cotransporter, which can be found in the distal convoluted tubule of the kidney.

Magnesium deficiency is an electrolyte disturbance in which there is a low level of magnesium in the body. Symptoms include tremor, poor coordination, muscle spasms, loss of appetite, personality changes, and nystagmus. Complications may include seizures or cardiac arrest such as from torsade de pointes. Those with low magnesium often have low potassium.

<span class="mw-page-title-main">Metabolic alkalosis</span> Abnormally high tissue pH due to metabolic dysfunction

Metabolic alkalosis is an acid-base disorder in which the pH of tissue is elevated beyond the normal range (7.35–7.45). This is the result of decreased hydrogen ion concentration, leading to increased bicarbonate, or alternatively a direct result of increased bicarbonate concentrations. The condition typically cannot last long if the kidneys are functioning properly.

<span class="mw-page-title-main">Hyperaldosteronism</span> Excess aldosterone in the body

Hyperaldosteronism is a medical condition wherein too much aldosterone is produced. High aldosterone levels can lead to lowered levels of potassium in the blood (hypokalemia) and increased hydrogen ion excretion (alkalosis). Aldosterone is normally produced in the adrenal glands.

<span class="mw-page-title-main">Liddle's syndrome</span> Medical condition

Liddle's syndrome, also called Liddle syndrome, is a genetic disorder inherited in an autosomal dominant manner that is characterized by early, and frequently severe, high blood pressure associated with low plasma renin activity, metabolic alkalosis, low blood potassium, and normal to low levels of aldosterone. Liddle syndrome involves abnormal kidney function, with excess reabsorption of sodium and loss of potassium from the renal tubule, and is treated with a combination of low sodium diet and potassium-sparing diuretics. It is extremely rare, with fewer than 30 pedigrees or isolated cases having been reported worldwide as of 2008.

<span class="mw-page-title-main">Bartter syndrome</span> Medical condition

Bartter syndrome (BS) is a rare inherited disease characterised by a defect in the thick ascending limb of the loop of Henle, which results in low potassium levels (hypokalemia), increased blood pH (alkalosis), and normal to low blood pressure. There are two types of Bartter syndrome: neonatal and classic. A closely associated disorder, Gitelman syndrome, is milder than both subtypes of Bartter syndrome.

Pseudohyperaldosteronism is a medical condition which mimics the effects of elevated aldosterone (hyperaldosteronism) by presenting with high blood pressure, low blood potassium levels (hypokalemia), metabolic alkalosis, and low levels of plasma renin activity (PRA). However, unlike hyperaldosteronism, this conditions exhibits low or normal levels of aldosterone in the blood. Causes include genetic disorders, acquired conditions, metabolic disorders, and dietary imbalances including excessive consumption of licorice. Confirmatory diagnosis depends on the specific cause and may involve blood tests, urine tests, or genetic testing; however, all forms of this condition exhibit abnormally low concentrations of both plasma renin activity (PRA) and plasma aldosterone concentration (PAC) which differentiates this group of conditions from other forms of secondary hypertension. Treatment is tailored to the specific cause and focuses on symptom control, blood pressure management, and avoidance of triggers.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Soar J, Perkins GD, Abbas G, Alfonzo A, Barelli A, Bierens JJ, Brugger H, Deakin CD, Dunning J, Georgiou M, Handley AJ, Lockey DJ, Paal P, Sandroni C, Thies KC, Zideman DA, Nolan JP (October 2010). "European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution". Resuscitation. 81 (10): 1400–33. doi:10.1016/j.resuscitation.2010.08.015. PMID   20956045.
  2. 1 2 Pathy MJ (2006). "Appendix 1: Conversion of SI Units to Standard Units". Principles and Practice of Geriatric Medicine. Vol. 2 (4. ed.). Chichester: Wiley. p. Appendix. doi:10.1002/047009057X.app01. ISBN   978-0-470-09055-8.
  3. 1 2 3 4 5 6 Zieg J, Gonsorcikova L, Landau D (July 2016). "Current views on the diagnosis and management of hypokalaemia in children". Acta Paediatrica. 105 (7): 762–72. doi:10.1111/apa.13398. PMID   26972906. S2CID   19579505.
  4. 1 2 3 4 Marx J, Walls R, Hockberger R (2013). Rosen's Emergency Medicine - Concepts and Clinical Practice (8 ed.). Elsevier Health Sciences. p. 1639. ISBN   978-1-4557-4987-4. Archived from the original on 2016-08-15.
  5. Herlihy B (2014). The Human Body in Health and Illness. Elsevier Health Sciences. p. 487. ISBN   978-1-4557-5642-1. Archived from the original on 2016-10-01.
  6. 1 2 Krishna GG, Miller E, Kapoor S (1989). "Increased blood pressure during potassium depletion in normotensive men". The New England Journal of Medicine. 320 (18): 1177–82. doi:10.1056/NEJM198905043201804. PMID   2624617.
  7. Jain VV, Gupta OP, Jajoo SU, Khiangate B (January 2011). "Hypokalemia induced rhabdomyolysis". Indian Journal of Nephrology. 21 (1): 66. doi: 10.4103/0971-4065.78085 . PMC   3109789 . PMID   21655176.
  8. Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu AS, Brenner BM (2011). Brenner and Rector's The Kidney E-Book. Elsevier Health Sciences. p. 618. ISBN   978-1-4557-2304-1.
  9. "Symptoms and Signs of Low Potassium (Hypokalemia)" . Retrieved 2021-04-21.
  10. Hong E (2016). "Hypokalemia and Psychosis: A Forgotten Association". American Journal of Psychiatry Residents' Journal. 11 (11): 6–7. doi: 10.1176/appi.ajp-rj.2016.111103 .
  11. Cadwallader AB, De La Torre X, Tieri A, Botrè F (September 2010). "The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis: Diuretics in sport doping". British Journal of Pharmacology. 161 (1): 1–16. doi:10.1111/j.1476-5381.2010.00789.x. PMC   2962812 . PMID   20718736.
  12. Mascolo M, Chu ES, Mehler PS (April 2011). "Abuse and clinical value of diuretics in eating disorders therapeutic applications". International Journal of Eating Disorders. 44 (3): 200–202. doi:10.1002/eat.20814. PMID   20186716.
  13. Silverthorn DU (2016). Human Physiology: An Integrated Approach (7th ed.). Pearson Education. pp. 646–647. ISBN   978-0-321-98122-6.
  14. Walmsley RN, White GH (August 1984). "Occult causes of hypokalaemia". Clin. Chem. 30 (8): 1406–8. doi: 10.1093/clinchem/30.8.1406 . PMID   6744598.
  15. Halperin ML, Kamel KS (1998). "Potassium". Lancet. 352 (9122): 135–40. doi:10.1016/S0140-6736(98)85044-7. PMID   9672294. S2CID   208790031.
  16. Whyte KF, Addis GJ, Whitesmith R, Reid JL (April 1987). "Failure of chronic theophylline therapy to alter circulating catecholamines". Eur J Respir Dis. 70 (4): 221–8. PMID   3582518.
  17. Veltri KT, Mason C (March 2015). "Medication-induced hypokalemia". P & T: A Peer-Reviewed Journal for Formulary Management. 40 (3): 185–190. ISSN   1052-1372. PMC   4357351 . PMID   25798039.
  18. Charach G, Karniel E, Grosskopf I, Rabinovich A, Charach L (2 July 2020). "Methylphenidate has mild hyperglycemic and hypokalemia effects and increases leukocyte and neutrophil counts". Medicine. 99 (27): e20931. doi:10.1097/MD.0000000000020931. eISSN   1536-5964. ISSN   0025-7974. PMC   7337440 . PMID   32629693.
  19. Alazami M (8 February 2006). "Unusual causes of hypokalaemia and paralysis". QJM. 99 (3): 181–192. doi: 10.1093/qjmed/hcl011 . ISSN   1460-2725. PMID   16469765.
  20. Tsimihodimos V, Kakaidi V, Elisaf M (June 2009). "Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications". International Journal of Clinical Practice. 63 (6): 900–2. doi: 10.1111/j.1742-1241.2009.02051.x . PMID   19490200. S2CID   26191242.
  21. Shirley DG, Walter SJ, Noormohamed FH (November 2002). "Natriuretic effect of caffeine: assessment of segmental sodium reabsorption in humans". Clin. Sci. 103 (5): 461–6. doi:10.1042/cs1030461. PMID   12401118. S2CID   18740906.
  22. Packer, C.D. (June 2009). "Cola-induced hypokalaemia: a super-sized problem". International Journal of Clinical Practice. 63 (6): 833–5. doi:10.1111/j.1742-1241.2009.02066.x. PMID   19490191. S2CID   2856903.
  23. HealthGuru (2012-03-01). "Health.yahoo.com". Health.yahoo.com. Archived from the original on 2009-06-12. Retrieved 2012-03-10.
  24. Sodi R, Davison AS, Holmes E, Hine TJ, Roberts NB (June 2009). "The phenomenon of seasonal pseudohypokalemia: effects of ambient temperature, plasma glucose and role for sodium-potassium-exchanging-ATPase". Clin. Biochem. 42 (9): 813–8. doi:10.1016/j.clinbiochem.2009.01.024. PMID   19232334.
  25. 1 2 Khan E, Spiers C, Khan M (March 2013). "The heart and potassium: a banana republic". Acute Cardiac Care. 15 (1): 17–24. doi:10.3109/17482941.2012.741250. PMID   23425010. S2CID   35971172.
  26. "Potassium (Unit Conversion)". MediCalc. Archived from the original on 1 October 2016. Retrieved 27 September 2016.
  27. Levi's JT (2012). "ECG Diagnosis: Hypokalemia". The Permanente Journal. 16 (2): 57. doi:10.7812/tpp/12-015. PMC   3383164 . PMID   22745618.
  28. Ingelfinger JR (1 July 2015). "Fluids and Electrolytes Challenge - Disorders of Fluids and Electrolytes - Integrated View of Potassium Homeostasis". New England Journal of Medicine. doi:10.1056/feature.2015.06.16.43 (inactive 1 November 2024). Retrieved 16 November 2017.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
  29. "Sources of Dietary Potassium" (PDF). University of Massachusetts Medical School. Archived from the original (PDF) on 3 January 2017. Retrieved 3 February 2017.
  30. 1 2 3 4 Cohn JN, Kowey PR, Whelton PK, Prisant LM (2000-09-11). "New Guidelines for Potassium Replacement in Clinical Practice". Archives of Internal Medicine. 160 (16): 2429–36. doi: 10.1001/archinte.160.16.2429 . PMID   10979053.
  31. 1 2 3 Kraft MD, Btaiche IF, Sacks GS, Kudsk KA (2005-08-15). "Treatment of electrolyte disorders in adult patients in the intensive care unit". American Journal of Health-System Pharmacy. 62 (16): 1663–1682. doi:10.2146/ajhp040300. PMID   16085929.
  32. "How should intravenous (IV) potassium chloride be administered in adults? – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice". www.sps.nhs.uk. Archived from the original on 2018-10-16. Retrieved 2018-10-16.
  33. "Safety Issues With Adding Lidocaine to IV Potassium Infusions (Excerpt)". Archived from the original on 2008-12-22. Retrieved 2009-05-09.
  34. Clute J (2003). "Wiser Book". Scores: Reviews 1993–2003. Harold Wood, London, UK: Beccon. ISBN   978-1-870824-47-7. OCLC   53123451 . Retrieved 13 August 2019. Originally published as "Excessive Candor" no. 48 in Science Fiction Weekly no. 48, 16 June 1997.
  35. Di Filippo P (8 June 1997). "Destiny's Road". The Universe of Larry Niven. Archived from the original on 22 November 2019. Retrieved 13 August 2019. Reprints the review from the July 1997 issue of Science Fiction Age .
  36. Niven L (17 August 2010). Destiny's road. ISBN   9780312851224. OL   1012547M.{{cite book}}: |work= ignored (help)
  37. "Review of Destiny's Road by Larry Niven". Ambidexteri (Blog). 26 January 2013. Retrieved 4 August 2019.[ unreliable source? ]

Further reading